Tuesday, March 04, 2025 | 08:16 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Zydus receives USFDA tentative approval for Pregabalin Capsules

Image

Capital Market
Zydus Cadila has received a tentative approval from USFDA for Pregabalin Capsules (US RLD Lyrica) in the strengths of 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg and 300 mg. It will be manufactured at the group's formulations manufacturing facility at Moraiya, Ahmedabad. Pregabalin is used to help control certain kinds of seizures, painful nerve diseases and fibromyalgia.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Dec 15 2018 | 4:03 PM IST

Explore News